Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans

计划入组 8 人 · 首次发布于 2008 年 2 月 28 日

Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans

计划入组 11 人 · 首次发布于 2008 年 2 月 28 日

24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

计划入组 12 人 · 首次发布于 2009 年 1 月 7 日

dopamine D2 receptor positive allosteric modulators (UCB Pharma)

Quinagolide

C₂₀H₃₃N₃O₃S · Rx

Itopride

C₂₀H₂₆N₂O₄ · Rx

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Veru Inc

United States

IQVIA Gains CDSCO Panel Approval for Phase III Lumateperone Trial in Pediatric Bipolar Depression

NG101 Shows Promise in Phase 2 Trial for GLP-1-Induced Nausea and Vomiting

Drug repurposing screen identifies dopamine signaling and COX inhibition as candidate therapeutic pathways for PIGA-CDG